Modern antidiabetic therapy by sodium-glucose cotransporter 2 inhibitors, glucagon-like peptide 1 receptor agonists, and dipeptidyl peptidase 4 inhibitors against cardiovascular diseases.

鈉-葡萄糖共轉運蛋白2抑制劑、GLP-1受體促效劑及DPP-4抑制劑於現代抗糖尿病治療對心血管疾病的作用